Trial Profile
Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Ketoconazole (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 08 Apr 2009 New trial record